BBLG Bone Biologics Corporation
Fundamentals / CIK 0001419554 / USDBone Biologics Corporation reported $6.43M in total assets and a net loss of $2.84M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open BBLG in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$3.01M Operating profit
-
Net Income FY 2025-$2.84M GAAP bottom line
-
Diluted EPS FY 2025-$0.76 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$6.09M Total debt: --
Annual revenue and net income
10 fiscal years (2016 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- | $1.07B | $1.07B | -- | -- | -- |
| Research & Development | $1.06M | $2.13M | $6.91M | $1.58M | $82K | $341K | $1.10M | $104K | $1.42M | $10.17M |
| Total Operating Expenses | $3.23M | $4.22M | $9.43M | $3.67M | $1.10M | $825K | $2.45M | $2.79M | $2.63M | $20.41M |
| Operating Income | -$3.23M | -$4.22M | -$9.43M | -$3.67M | -$1.10M | -$825K | -$2.45M | -$2.79M | -$2.63M | -$20.41M |
| EBITDA | -- | -- | -- | -- | -- | -- | -$2.45M | -$2.79M | -$2.63M | -$20.41M |
| Interest Income | $122K | $56K | $1.9K | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -- | -- | -- | -- | -$1.61M | -$1.82M | -$3.42M | -$4.43M | -$7.05M | -$25.88M |
| Income Tax Expense | -- | -- | -- | -- | $1.6K | $1.6K | $1.6K | $1.7K | $1.6K | $2.2K |
| Net Income | -$3.11M | -$4.11M | -$8.95M | -$1.48M | -$1.61M | -$1.82M | -$3.42M | -$4.43M | -$7.05M | -$25.88M |
| Basic EPS | -$2.65 | -$28.96 | -$204.26 | -$2,957,304.83 | -$997,842.17 | -$1,796,115.90 | -$1,339,959.48 | -$2,508,860.31 | -$5,160,269.50 | -$1,967,174.56 |
| Diluted EPS | -$2.65 | -$28.96 | -$204.26 | -$2,957,304.83 | -$997,842.17 | -$1,796,115.90 | -$1,339,959.48 | -$2,508,860.31 | -$5,160,269.50 | -$1,967,174.56 |
| Basic Shares Outstanding | 1.2M | 253.0K | 43.8K | 1 | 2 | 1 | 3 | 2 | 1 | 13 |
| Diluted Shares Outstanding | 1.2M | 253.0K | 43.8K | 1 | 2 | 1 | 3 | 2 | 1 | 13 |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $243K | $309K | $142K | $257K | $188K | $192K | $424K | $1.10M |
| Total Operating Expenses | $666K | $808K | $805K | $733K | $715K | $748K | $1.04M | $1.55M |
| Operating Income | -$666K | -$808K | -$805K | -$733K | -$715K | -$748K | -$1.04M | -$1.55M |
| Interest Income | $48K | $35K | $39K | $48K | $47K | $6.7K | $20K | $20K |
| Net Income | -$618K | -$774K | -$766K | -$685K | -$667K | -$741K | -$1.02M | -$1.52M |
| Basic EPS | -$0.17 | -$0.43 | -$0.43 | -- | -$0.37 | -$1.33 | -$1.92 | -- |
| Diluted EPS | -$0.17 | -$0.43 | -$0.43 | -- | -$0.37 | -$1.33 | -$1.92 | -- |
| Basic Shares Outstanding | 3.7M | 1.8M | 1.8M | -- | 1.8M | 557.8K | 530.6K | -- |
| Diluted Shares Outstanding | 3.7M | 1.8M | 1.8M | -- | 1.8M | 557.8K | 530.6K | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $5.33M | $3.33M | $3.03M | $7.54M | $6.68M | -- | $24K | $955K | $690K | $1.62M |
| Cash & Short-Term Investments | $5.33M | $3.33M | $3.03M | $7.54M | $6.68M | -- | $24K | $955K | $690K | $1.62M |
| Total Current Assets | $5.80M | $3.86M | $3.74M | $8.50M | -- | -- | $31K | $1.04M | $796K | $1.67M |
| Property, Plant & Equipment, Net | -- | -- | -- | -- | -- | -- | -- | $50 | $146 | $170 |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | -- | -- | $0 | $50 | $146 | $170 |
| Total Assets | $5.80M | $3.86M | $3.74M | $8.50M | $6.68M | $0 | $31K | $1.04M | $796K | $1.67M |
| Accounts Payable | -- | -- | -- | -- | -- | $465K | $43K | $125K | $217K | $225K |
| Total Current Liabilities | $419K | $378K | $831K | $2.55M | $100K | $13.69M | $578K | $9.64M | $962K | $3.82M |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $11.32M | $0 | $8.23M | $8.03M |
| Total Liabilities | $419K | $378K | $831K | $2.55M | $100K | $13.69M | $11.90M | $9.64M | $9.19M | $11.85M |
| Common Stock | $1.8K | $492 | $534 | $64 | $10K | $12K | $31K | $26K | $4.3K | $39K |
| Retained Earnings | -$88.13M | -$85.02M | -$80.91M | -$71.96M | -$70.48M | -$68.86M | -$67.04M | -$63.62M | -$59.19M | $56.42M |
| Total Stockholders' Equity | $5.38M | $3.48M | $2.91M | $5.95M | $6.58M | -$13.69M | -$11.87M | -$8.60M | -$8.40M | -$10.18M |
| Total Equity | $5.38M | $3.48M | $2.91M | $5.95M | $6.58M | -$13.69M | -$11.87M | -$8.60M | -$8.40M | -$10.18M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $6.09M | $4.03M | $4.53M | $5.33M | $6.05M | $6.64M | $2.75M | $3.33M |
| Cash & Short-Term Investments | $6.09M | $4.03M | $4.53M | $5.33M | $6.05M | $6.64M | $2.75M | $3.33M |
| Total Current Assets | $6.43M | $4.44M | $4.98M | $5.80M | $6.35M | $7.00M | $3.16M | $3.86M |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $6.43M | $4.44M | $4.98M | $5.80M | $6.35M | $7.00M | $3.16M | $3.86M |
| Total Current Liabilities | $481K | $512K | $309K | $419K | $334K | $406K | $251K | $378K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $481K | $512K | $309K | $419K | $334K | $406K | $251K | $378K |
| Common Stock | $3.4K | $1.8K | $1.8K | $1.8K | $1.8K | $1.7K | $3.3K | $492 |
| Retained Earnings | -$90.29M | -$89.67M | -$88.90M | -$88.13M | -$87.45M | -$86.78M | -$86.04M | -$85.02M |
| Total Stockholders' Equity | $5.95M | $3.92M | $4.67M | $5.38M | $6.02M | $6.60M | $2.91M | $3.48M |
| Total Equity | $5.95M | $3.92M | $4.67M | $5.38M | $6.02M | $6.60M | $2.91M | $3.48M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.10M | -$4.11M | -$8.95M | -$1.48M | -$1.61M | -$1.82M | -$3.42M | -$4.43M | -$7.05M | -$25.88M |
| Depreciation & Amortization | -- | -- | -- | -- | -- | -- | $50 | $96 | $96 | $700 |
| Stock-Based Compensation | $256K | $189K | $153K | $267K | $207K | -- | $50K | $517K | $1.62M | $4.14M |
| Operating Cash Flow | -$2.69M | -$4.12M | -$9.56M | -$3.57M | -$1.23M | -$427K | -$3.25M | -$4.10M | -$3.33M | -$7.33M |
| Common Stock Issued | $4.35M | $1.50M | $5.04M | $4.43M | $6.86M | -- | -- | $4.37M | $700K | $2.50M |
| Financing Cash Flow | $4.70M | $4.42M | $5.04M | $4.43M | $7.90M | $403K | $2.32M | $4.37M | $3.40M | $6.83M |
| Net Change in Cash | $2.01M | $299K | -$4.51M | $863K | $6.68M | -$24K | -$931K | $265K | $70K | -$495K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$700K | -$700K | -$800K | -$685K | -$667K | -$741K | -$1.02M | -$1.52M |
| Stock-Based Compensation | $3.4K | $8.3K | $24K | $46K | $87K | $73K | $51K | $101K |
| Operating Cash Flow | -$532K | -$518K | -$804K | -$715K | -$591K | -$459K | -$926K | -$1.35M |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | $0 |
| Financing Cash Flow | -- | -- | -- | $0 | $0 | $4.35M | $348K | $1.11M |
| Net Change in Cash | $2.06M | -$498K | -$804K | -$715K | -$591K | $3.89M | -$579K | -$241K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -- | -- | -- | -- | -- | -0.1% | -0.2% | -- | -- | -- |
| Net Profit Margin | -- | -- | -- | -- | -- | -0.2% | -0.3% | -- | -- | -- |
| Return on Equity (ROE) | -57.8% | -118.0% | -307.9% | -25.0% | -24.5% | -- | -- | -- | -- | -- |
| Return on Assets (ROA) | -53.6% | -106.5% | -239.4% | -17.5% | -24.1% | -- | -11109.8% | -425.7% | -886.3% | -3690.9% |
| Current Ratio | 13.85x | 10.22x | 4.50x | 3.33x | -- | -- | 0.05x | 0.11x | 0.83x | 0.47x |
| Quick Ratio | 12.74x | 8.80x | 3.64x | 2.96x | 66.81x | -- | 0.04x | 0.10x | 0.72x | 0.41x |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | 0.0% | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -47.8% | -73.7% | -61.2% | -57.8% | -65.6% | -64.0% | -146.5% | -118.0% |
| Return on Assets (ROA) | -44.2% | -65.2% | -57.4% | -53.6% | -62.1% | -60.3% | -134.8% | -106.5% |
| Current Ratio | 13.38x | 8.67x | 16.09x | 13.85x | 19.00x | 17.24x | 12.59x | 10.22x |
| Quick Ratio | 12.66x | 7.87x | 14.64x | 12.74x | 18.10x | 16.35x | 10.94x | 8.80x |